Glover Ebony M, Davis Michael
Department of Psychology, Emory University, Atlanta, GA, USA.
Psychopharmacology (Berl). 2008 Jun;198(2):167-80. doi: 10.1007/s00213-008-1112-0. Epub 2008 Mar 7.
Morphine and buprenorphine have analgesic and anxiolytic-like properties. While their analgesic effects have been well characterized, their anxiolytic-like properties have not.
Effects of acute morphine and buprenorphine on the expression of acoustic fear-potentiated startle (FPS) and naloxone pretreatment were assessed. Effects of chronic morphine and buprenorphine on tolerance, cross-tolerance, and withdrawal were also examined.
Fear-conditioned rats were given subcutaneous drug treatment immediately before testing for FPS. Experiment 1, rats were administered morphine (0.03, 0.25, 0.63, 2.5, or 10 mg/kg) or buprenorphine (0.004, 0.0075, 0.015, 0.03, or 0.25 mg/kg). Experiment 2, rats were given saline or naloxone (0.5 mg/kg) and 5 min later given saline, morphine (2.5 mg/kg), or buprenorphine (0.03 mg/kg). Experiment 3, rats received once-daily injections of saline, morphine (10 mg/kg), or buprenorphine (0.25 mg/kg) for 7 days. Immediately before testing, saline-treated rats were given saline, morphine (2.5 mg/kg), or buprenorphine (0.03 mg/kg), morphine-treated rats were given morphine (2.5 mg/kg) or buprenorphine (0.03 mg/kg), and buprenorphine-treated rats were given buprenorphine (0.03 mg/kg) or morphine (2.5 mg/kg). Tolerance and cross-tolerance in analgesia were assessed via the tail-flick test, as were naloxone-precipitated withdrawal.
Morphine and buprenorphine had parallel dose-response curves in blocking FPS, with buprenorphine 40 times more potent than morphine. Naloxone reversed these effects. Morphine and buprenorphine showed tolerance and cross-tolerance in their anxiolytic-like and analgesic effects. Chronic buprenorphine produced less withdrawal than chronic morphine.
Cross-tolerance between morphine and buprenorphine suggests a common receptor mediating their anxiolytic-like and analgesic effects.
吗啡和丁丙诺啡具有镇痛和抗焦虑样特性。虽然它们的镇痛作用已得到充分表征,但其抗焦虑样特性尚未明确。
评估急性吗啡和丁丙诺啡对听觉恐惧增强惊吓反应(FPS)表达的影响以及纳洛酮预处理的作用。还研究了慢性吗啡和丁丙诺啡对耐受性、交叉耐受性和戒断反应的影响。
对经过恐惧条件训练的大鼠在进行FPS测试前立即给予皮下药物治疗。实验1,给大鼠注射吗啡(0.03、0.25、0.63、2.5或10毫克/千克)或丁丙诺啡(0.004、0.0075、0.015、0.03或0.25毫克/千克)。实验2,给大鼠注射生理盐水或纳洛酮(0.5毫克/千克),5分钟后再注射生理盐水、吗啡(2.5毫克/千克)或丁丙诺啡(0.03毫克/千克)。实验3,大鼠连续7天每天注射一次生理盐水、吗啡(10毫克/千克)或丁丙诺啡(0.25毫克/千克)。在测试前,给生理盐水处理的大鼠注射生理盐水、吗啡(2.5毫克/千克)或丁丙诺啡(0.03毫克/千克),给吗啡处理的大鼠注射吗啡(2.5毫克/千克)或丁丙诺啡(0.03毫克/千克),给丁丙诺啡处理的大鼠注射丁丙诺啡(0.03毫克/千克)或吗啡(2.5毫克/千克)。通过甩尾试验评估镇痛中的耐受性和交叉耐受性,以及纳洛酮诱发的戒断反应。
吗啡和丁丙诺啡在阻断FPS方面具有平行的剂量反应曲线,丁丙诺啡的效力比吗啡强40倍。纳洛酮可逆转这些作用。吗啡和丁丙诺啡在其抗焦虑样和镇痛作用方面表现出耐受性和交叉耐受性。慢性丁丙诺啡产生的戒断反应比慢性吗啡少。
吗啡和丁丙诺啡之间的交叉耐受性表明存在一种共同的受体介导它们的抗焦虑样和镇痛作用。